ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
DLX1
|
ENSG00000144355.10 | DLX1 |
HOXA3
|
ENSG00000105997.18 | HOXA3 |
BARX2
|
ENSG00000043039.5 | BARX2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BARX2 | hg19_v2_chr11_+_129245796_129245835 | 0.32 | 2.3e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_-_15918618 | 4.76 |
ENST00000400564.1 ENST00000400566.1 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
chr6_-_32908792 | 3.76 |
ENST00000418107.2 |
HLA-DMB |
major histocompatibility complex, class II, DM beta |
chr17_+_67498538 | 3.27 |
ENST00000589647.1 |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
chr16_-_28634874 | 3.08 |
ENST00000395609.1 ENST00000350842.4 |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
chr17_-_64225508 | 2.87 |
ENST00000205948.6 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chrX_-_130423200 | 2.60 |
ENST00000361420.3 |
IGSF1 |
immunoglobulin superfamily, member 1 |
chr4_+_88896819 | 2.45 |
ENST00000237623.7 ENST00000395080.3 ENST00000508233.1 ENST00000360804.4 |
SPP1 |
secreted phosphoprotein 1 |
chr15_+_58702742 | 2.42 |
ENST00000356113.6 ENST00000414170.3 |
LIPC |
lipase, hepatic |
chr18_+_32556892 | 2.33 |
ENST00000591734.1 ENST00000413393.1 ENST00000589180.1 ENST00000587359.1 |
MAPRE2 |
microtubule-associated protein, RP/EB family, member 2 |
chr1_-_212965104 | 2.21 |
ENST00000422588.2 ENST00000366975.6 ENST00000366977.3 ENST00000366976.1 |
NSL1 |
NSL1, MIS12 kinetochore complex component |
chr19_+_45417921 | 2.20 |
ENST00000252491.4 ENST00000592885.1 ENST00000589781.1 |
APOC1 |
apolipoprotein C-I |
chr14_-_25479811 | 2.13 |
ENST00000550887.1 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
chr7_-_87342564 | 1.99 |
ENST00000265724.3 ENST00000416177.1 |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
chr7_+_138145076 | 1.97 |
ENST00000343526.4 |
TRIM24 |
tripartite motif containing 24 |
chr1_-_92952433 | 1.94 |
ENST00000294702.5 |
GFI1 |
growth factor independent 1 transcription repressor |
chr12_-_22063787 | 1.85 |
ENST00000544039.1 |
ABCC9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
chr6_-_32908765 | 1.84 |
ENST00000416244.2 |
HLA-DMB |
major histocompatibility complex, class II, DM beta |
chr16_-_30122717 | 1.84 |
ENST00000566613.1 |
GDPD3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
chr4_+_71063641 | 1.82 |
ENST00000514097.1 |
ODAM |
odontogenic, ameloblast asssociated |
chr10_-_101825151 | 1.75 |
ENST00000441382.1 |
CPN1 |
carboxypeptidase N, polypeptide 1 |
chr6_+_89674246 | 1.74 |
ENST00000369474.1 |
AL079342.1 |
Uncharacterized protein; cDNA FLJ27030 fis, clone SLV07741 |
chr7_-_124569991 | 1.69 |
ENST00000446993.1 ENST00000357628.3 ENST00000393329.1 |
POT1 |
protection of telomeres 1 |
chr11_+_121447469 | 1.66 |
ENST00000532694.1 ENST00000534286.1 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
chr14_-_23426270 | 1.66 |
ENST00000557591.1 ENST00000397409.4 ENST00000490506.1 ENST00000554406.1 |
HAUS4 |
HAUS augmin-like complex, subunit 4 |
chr15_-_20193370 | 1.66 |
ENST00000558565.2 |
IGHV3OR15-7 |
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr14_-_23426337 | 1.61 |
ENST00000342454.8 ENST00000555986.1 ENST00000541587.1 ENST00000554516.1 ENST00000347758.2 ENST00000206474.7 ENST00000555040.1 |
HAUS4 |
HAUS augmin-like complex, subunit 4 |
chr14_-_23426322 | 1.59 |
ENST00000555367.1 |
HAUS4 |
HAUS augmin-like complex, subunit 4 |
chrX_+_78200913 | 1.58 |
ENST00000171757.2 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
chr17_+_48823896 | 1.55 |
ENST00000511974.1 |
LUC7L3 |
LUC7-like 3 (S. cerevisiae) |
chr4_-_185275104 | 1.51 |
ENST00000317596.3 |
RP11-290F5.2 |
RP11-290F5.2 |
chr15_-_37393406 | 1.48 |
ENST00000338564.5 ENST00000558313.1 ENST00000340545.5 |
MEIS2 |
Meis homeobox 2 |
chr4_+_74269956 | 1.47 |
ENST00000295897.4 ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB |
albumin |
chr19_+_50016411 | 1.47 |
ENST00000426395.3 ENST00000600273.1 ENST00000599988.1 |
FCGRT |
Fc fragment of IgG, receptor, transporter, alpha |
chrX_+_78200829 | 1.44 |
ENST00000544091.1 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
chr14_-_106668095 | 1.37 |
ENST00000390606.2 |
IGHV3-20 |
immunoglobulin heavy variable 3-20 |
chr19_+_50016610 | 1.37 |
ENST00000596975.1 |
FCGRT |
Fc fragment of IgG, receptor, transporter, alpha |
chr12_-_23737534 | 1.37 |
ENST00000396007.2 |
SOX5 |
SRY (sex determining region Y)-box 5 |
chr10_+_7745232 | 1.37 |
ENST00000358415.4 |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
chr4_+_80584903 | 1.34 |
ENST00000506460.1 |
RP11-452C8.1 |
RP11-452C8.1 |
chr16_+_12059050 | 1.34 |
ENST00000396495.3 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr14_-_94789663 | 1.33 |
ENST00000557225.1 ENST00000341584.3 |
SERPINA6 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
chr3_-_141747950 | 1.31 |
ENST00000497579.1 |
TFDP2 |
transcription factor Dp-2 (E2F dimerization partner 2) |
chr16_+_12059091 | 1.30 |
ENST00000562385.1 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr10_+_7745303 | 1.29 |
ENST00000429820.1 ENST00000379587.4 |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
chr14_-_106552755 | 1.26 |
ENST00000390600.2 |
IGHV3-9 |
immunoglobulin heavy variable 3-9 |
chr6_-_32157947 | 1.26 |
ENST00000375050.4 |
PBX2 |
pre-B-cell leukemia homeobox 2 |
chr14_-_107049312 | 1.25 |
ENST00000390627.2 |
IGHV3-53 |
immunoglobulin heavy variable 3-53 |
chr14_+_95027772 | 1.24 |
ENST00000555095.1 ENST00000298841.5 ENST00000554220.1 ENST00000553780.1 |
SERPINA4 SERPINA5 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
chr10_+_114133773 | 1.24 |
ENST00000354655.4 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
chr1_+_198608146 | 1.24 |
ENST00000367376.2 ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
chr17_+_1674982 | 1.23 |
ENST00000572048.1 ENST00000573763.1 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr2_+_90077680 | 1.23 |
ENST00000390270.2 |
IGKV3D-20 |
immunoglobulin kappa variable 3D-20 |
chrX_-_110655306 | 1.22 |
ENST00000371993.2 |
DCX |
doublecortin |
chr13_-_41593425 | 1.13 |
ENST00000239882.3 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
chr1_+_236958554 | 1.11 |
ENST00000366577.5 ENST00000418145.2 |
MTR |
5-methyltetrahydrofolate-homocysteine methyltransferase |
chr22_+_18632666 | 1.07 |
ENST00000215794.7 |
USP18 |
ubiquitin specific peptidase 18 |
chr2_+_187371440 | 1.07 |
ENST00000445547.1 |
ZC3H15 |
zinc finger CCCH-type containing 15 |
chr6_+_31895254 | 1.06 |
ENST00000299367.5 ENST00000442278.2 |
C2 |
complement component 2 |
chr12_+_100867486 | 1.06 |
ENST00000548884.1 |
NR1H4 |
nuclear receptor subfamily 1, group H, member 4 |
chr8_-_101571933 | 1.05 |
ENST00000520311.1 |
ANKRD46 |
ankyrin repeat domain 46 |
chr4_+_69681710 | 1.04 |
ENST00000265403.7 ENST00000458688.2 |
UGT2B10 |
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr14_-_90085458 | 1.03 |
ENST00000345097.4 ENST00000555855.1 ENST00000555353.1 |
FOXN3 |
forkhead box N3 |
chr7_+_116660246 | 1.02 |
ENST00000434836.1 ENST00000393443.1 ENST00000465133.1 ENST00000477742.1 ENST00000393447.4 ENST00000393444.3 |
ST7 |
suppression of tumorigenicity 7 |
chr6_+_26365443 | 1.02 |
ENST00000527422.1 ENST00000356386.2 ENST00000396934.3 ENST00000377708.2 ENST00000396948.1 ENST00000508906.2 |
BTN3A2 |
butyrophilin, subfamily 3, member A2 |
chr8_-_101571964 | 1.01 |
ENST00000520552.1 ENST00000521345.1 ENST00000523000.1 ENST00000335659.3 ENST00000358990.3 ENST00000519597.1 |
ANKRD46 |
ankyrin repeat domain 46 |
chr2_+_11696464 | 1.01 |
ENST00000234142.5 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr16_+_82090028 | 0.99 |
ENST00000568090.1 |
HSD17B2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
chr8_-_90996459 | 0.99 |
ENST00000517337.1 ENST00000409330.1 |
NBN |
nibrin |
chr16_-_28621353 | 0.99 |
ENST00000567512.1 |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
chr1_-_190446759 | 0.98 |
ENST00000367462.3 |
BRINP3 |
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
chr18_+_55888767 | 0.98 |
ENST00000431212.2 ENST00000586268.1 ENST00000587190.1 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr14_-_106926724 | 0.97 |
ENST00000434710.1 |
IGHV3-43 |
immunoglobulin heavy variable 3-43 |
chr10_-_50970322 | 0.96 |
ENST00000374103.4 |
OGDHL |
oxoglutarate dehydrogenase-like |
chr17_+_79953310 | 0.96 |
ENST00000582355.2 |
ASPSCR1 |
alveolar soft part sarcoma chromosome region, candidate 1 |
chr6_+_13272904 | 0.95 |
ENST00000379335.3 ENST00000379329.1 |
PHACTR1 |
phosphatase and actin regulator 1 |
chr17_+_27369918 | 0.95 |
ENST00000323372.4 |
PIPOX |
pipecolic acid oxidase |
chrX_+_108779004 | 0.95 |
ENST00000218004.1 |
NXT2 |
nuclear transport factor 2-like export factor 2 |
chr17_-_48785216 | 0.93 |
ENST00000285243.6 |
ANKRD40 |
ankyrin repeat domain 40 |
chr1_-_197115818 | 0.91 |
ENST00000367409.4 ENST00000294732.7 |
ASPM |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
chr7_-_99717463 | 0.91 |
ENST00000437822.2 |
TAF6 |
TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa |
chr20_+_56136136 | 0.91 |
ENST00000319441.4 ENST00000543666.1 |
PCK1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr16_+_15489603 | 0.90 |
ENST00000568766.1 ENST00000287594.7 |
RP11-1021N1.1 MPV17L |
Uncharacterized protein MPV17 mitochondrial membrane protein-like |
chr16_-_55866997 | 0.90 |
ENST00000360526.3 ENST00000361503.4 |
CES1 |
carboxylesterase 1 |
chr1_-_75198940 | 0.89 |
ENST00000417775.1 |
CRYZ |
crystallin, zeta (quinone reductase) |
chr2_+_68592305 | 0.89 |
ENST00000234313.7 |
PLEK |
pleckstrin |
chr16_-_28621312 | 0.88 |
ENST00000314752.7 |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
chr10_-_50970382 | 0.88 |
ENST00000419399.1 ENST00000432695.1 |
OGDHL |
oxoglutarate dehydrogenase-like |
chr18_-_67624160 | 0.87 |
ENST00000581982.1 ENST00000280200.4 |
CD226 |
CD226 molecule |
chr8_-_17767866 | 0.86 |
ENST00000398056.2 |
FGL1 |
fibrinogen-like 1 |
chr14_+_39583427 | 0.85 |
ENST00000308317.6 ENST00000396249.2 ENST00000250379.8 ENST00000534684.2 ENST00000527381.1 |
GEMIN2 |
gem (nuclear organelle) associated protein 2 |
chr11_+_59824060 | 0.84 |
ENST00000395032.2 ENST00000358152.2 |
MS4A3 |
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) |
chr3_+_121774202 | 0.84 |
ENST00000469710.1 ENST00000493101.1 ENST00000330540.2 ENST00000264468.5 |
CD86 |
CD86 molecule |
chr6_-_89927151 | 0.83 |
ENST00000454853.2 |
GABRR1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
chr7_-_55930443 | 0.83 |
ENST00000388975.3 |
SEPT14 |
septin 14 |
chr16_-_28621298 | 0.81 |
ENST00000566189.1 |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
chr14_-_54423529 | 0.81 |
ENST00000245451.4 ENST00000559087.1 |
BMP4 |
bone morphogenetic protein 4 |
chr20_+_30697298 | 0.79 |
ENST00000398022.2 |
TM9SF4 |
transmembrane 9 superfamily protein member 4 |
chr22_-_30960876 | 0.79 |
ENST00000401975.1 ENST00000428682.1 ENST00000423299.1 |
GAL3ST1 |
galactose-3-O-sulfotransferase 1 |
chr1_+_70876891 | 0.78 |
ENST00000411986.2 |
CTH |
cystathionase (cystathionine gamma-lyase) |
chr12_-_719573 | 0.78 |
ENST00000397265.3 |
NINJ2 |
ninjurin 2 |
chr12_+_100867694 | 0.77 |
ENST00000392986.3 ENST00000549996.1 |
NR1H4 |
nuclear receptor subfamily 1, group H, member 4 |
chr7_+_150020363 | 0.77 |
ENST00000359623.4 ENST00000493307.1 |
LRRC61 |
leucine rich repeat containing 61 |
chr3_-_194072019 | 0.77 |
ENST00000429275.1 ENST00000323830.3 |
CPN2 |
carboxypeptidase N, polypeptide 2 |
chr7_+_116654935 | 0.76 |
ENST00000432298.1 ENST00000422922.1 |
ST7 |
suppression of tumorigenicity 7 |
chr6_+_153552455 | 0.76 |
ENST00000392385.2 |
AL590867.1 |
Uncharacterized protein; cDNA FLJ59044, highly similar to LINE-1 reverse transcriptase homolog |
chr2_+_90211643 | 0.75 |
ENST00000390277.2 |
IGKV3D-11 |
immunoglobulin kappa variable 3D-11 |
chr9_+_90112767 | 0.75 |
ENST00000408954.3 |
DAPK1 |
death-associated protein kinase 1 |
chr16_-_28608364 | 0.73 |
ENST00000533150.1 |
SULT1A2 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 |
chr9_+_108463234 | 0.73 |
ENST00000374688.1 |
TMEM38B |
transmembrane protein 38B |
chr6_+_28092338 | 0.73 |
ENST00000340487.4 |
ZSCAN16 |
zinc finger and SCAN domain containing 16 |
chr12_-_10282742 | 0.72 |
ENST00000298523.5 ENST00000396484.2 ENST00000310002.4 |
CLEC7A |
C-type lectin domain family 7, member A |
chr12_-_8088871 | 0.72 |
ENST00000075120.7 |
SLC2A3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
chr12_+_64798095 | 0.71 |
ENST00000332707.5 |
XPOT |
exportin, tRNA |
chr14_+_61654271 | 0.71 |
ENST00000555185.1 ENST00000557294.1 ENST00000556778.1 |
PRKCH |
protein kinase C, eta |
chr10_+_57358750 | 0.71 |
ENST00000512524.2 |
MTRNR2L5 |
MT-RNR2-like 5 |
chr12_-_112123524 | 0.70 |
ENST00000327551.6 |
BRAP |
BRCA1 associated protein |
chr4_-_105416039 | 0.70 |
ENST00000394767.2 |
CXXC4 |
CXXC finger protein 4 |
chr15_+_41057818 | 0.70 |
ENST00000558467.1 |
GCHFR |
GTP cyclohydrolase I feedback regulator |
chr6_+_64345698 | 0.69 |
ENST00000506783.1 ENST00000481385.2 ENST00000515594.1 ENST00000494284.2 ENST00000262043.3 |
PHF3 |
PHD finger protein 3 |
chr2_+_196313239 | 0.69 |
ENST00000413290.1 |
AC064834.1 |
AC064834.1 |
chr1_+_207277590 | 0.69 |
ENST00000367070.3 |
C4BPA |
complement component 4 binding protein, alpha |
chr1_+_101003687 | 0.68 |
ENST00000315033.4 |
GPR88 |
G protein-coupled receptor 88 |
chr1_+_70876926 | 0.68 |
ENST00000370938.3 ENST00000346806.2 |
CTH |
cystathionase (cystathionine gamma-lyase) |
chr11_+_59824127 | 0.68 |
ENST00000278865.3 |
MS4A3 |
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) |
chr11_+_7618413 | 0.67 |
ENST00000528883.1 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr1_-_160549235 | 0.67 |
ENST00000368054.3 ENST00000368048.3 ENST00000311224.4 ENST00000368051.3 ENST00000534968.1 |
CD84 |
CD84 molecule |
chr10_-_98031265 | 0.67 |
ENST00000224337.5 ENST00000371176.2 |
BLNK |
B-cell linker |
chr16_-_1464688 | 0.66 |
ENST00000389221.4 ENST00000508903.2 ENST00000397462.1 ENST00000301712.5 |
UNKL |
unkempt family zinc finger-like |
chr2_-_166930131 | 0.65 |
ENST00000303395.4 ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A |
sodium channel, voltage-gated, type I, alpha subunit |
chr6_+_25652432 | 0.65 |
ENST00000377961.2 |
SCGN |
secretagogin, EF-hand calcium binding protein |
chr1_-_150738261 | 0.65 |
ENST00000448301.2 ENST00000368985.3 |
CTSS |
cathepsin S |
chr16_-_29934558 | 0.64 |
ENST00000568995.1 ENST00000566413.1 |
KCTD13 |
potassium channel tetramerization domain containing 13 |
chr9_+_90112590 | 0.64 |
ENST00000472284.1 |
DAPK1 |
death-associated protein kinase 1 |
chr8_-_57123815 | 0.63 |
ENST00000316981.3 ENST00000423799.2 ENST00000429357.2 |
PLAG1 |
pleiomorphic adenoma gene 1 |
chr10_-_98031310 | 0.63 |
ENST00000427367.2 ENST00000413476.2 |
BLNK |
B-cell linker |
chr5_-_20575959 | 0.62 |
ENST00000507958.1 |
CDH18 |
cadherin 18, type 2 |
chr4_-_66536196 | 0.62 |
ENST00000511294.1 |
EPHA5 |
EPH receptor A5 |
chr3_-_105588231 | 0.62 |
ENST00000545639.1 ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chrX_-_20236970 | 0.62 |
ENST00000379548.4 |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chr22_+_40297079 | 0.61 |
ENST00000344138.4 ENST00000543252.1 |
GRAP2 |
GRB2-related adaptor protein 2 |
chr9_-_123676827 | 0.61 |
ENST00000546084.1 |
TRAF1 |
TNF receptor-associated factor 1 |
chr9_+_90112117 | 0.61 |
ENST00000358077.5 |
DAPK1 |
death-associated protein kinase 1 |
chr14_+_100485712 | 0.60 |
ENST00000544450.2 |
EVL |
Enah/Vasp-like |
chr16_-_28608424 | 0.60 |
ENST00000335715.4 |
SULT1A2 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 |
chr12_+_7014064 | 0.59 |
ENST00000443597.2 |
LRRC23 |
leucine rich repeat containing 23 |
chr19_+_42746927 | 0.59 |
ENST00000378108.1 |
AC006486.1 |
AC006486.1 |
chr5_+_129083772 | 0.59 |
ENST00000564719.1 |
KIAA1024L |
KIAA1024-like |
chr22_-_29107919 | 0.59 |
ENST00000434810.1 ENST00000456369.1 |
CHEK2 |
checkpoint kinase 2 |
chr3_+_46618727 | 0.58 |
ENST00000296145.5 |
TDGF1 |
teratocarcinoma-derived growth factor 1 |
chr17_-_18430160 | 0.58 |
ENST00000392176.3 |
FAM106A |
family with sequence similarity 106, member A |
chr9_+_2159850 | 0.58 |
ENST00000416751.1 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr3_-_196159268 | 0.57 |
ENST00000381887.3 ENST00000535858.1 ENST00000428095.1 ENST00000296328.4 |
UBXN7 |
UBX domain protein 7 |
chr12_-_12837423 | 0.56 |
ENST00000540510.1 |
GPR19 |
G protein-coupled receptor 19 |
chr5_-_42812143 | 0.56 |
ENST00000514985.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chr19_+_21324827 | 0.56 |
ENST00000600692.1 ENST00000599296.1 ENST00000594425.1 ENST00000311048.7 |
ZNF431 |
zinc finger protein 431 |
chr19_+_54466179 | 0.55 |
ENST00000270458.2 |
CACNG8 |
calcium channel, voltage-dependent, gamma subunit 8 |
chr10_+_35484793 | 0.55 |
ENST00000488741.1 ENST00000474931.1 ENST00000468236.1 ENST00000344351.5 ENST00000490511.1 |
CREM |
cAMP responsive element modulator |
chr22_+_40297105 | 0.55 |
ENST00000540310.1 |
GRAP2 |
GRB2-related adaptor protein 2 |
chr1_-_225616515 | 0.54 |
ENST00000338179.2 ENST00000425080.1 |
LBR |
lamin B receptor |
chr12_+_7014126 | 0.54 |
ENST00000415834.1 ENST00000436789.1 |
LRRC23 |
leucine rich repeat containing 23 |
chr16_+_72088376 | 0.54 |
ENST00000570083.1 ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP HPR |
haptoglobin haptoglobin-related protein |
chrX_+_84258832 | 0.54 |
ENST00000373173.2 |
APOOL |
apolipoprotein O-like |
chr5_-_42811986 | 0.53 |
ENST00000511224.1 ENST00000507920.1 ENST00000510965.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chr19_-_3985455 | 0.53 |
ENST00000309311.6 |
EEF2 |
eukaryotic translation elongation factor 2 |
chr4_+_113568207 | 0.53 |
ENST00000511529.1 |
LARP7 |
La ribonucleoprotein domain family, member 7 |
chr1_+_28199047 | 0.52 |
ENST00000373925.1 ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2 |
thymocyte selection associated family member 2 |
chr1_+_168148273 | 0.52 |
ENST00000367830.3 |
TIPRL |
TIP41, TOR signaling pathway regulator-like (S. cerevisiae) |
chr9_+_90112741 | 0.51 |
ENST00000469640.2 |
DAPK1 |
death-associated protein kinase 1 |
chr11_-_128894053 | 0.51 |
ENST00000392657.3 |
ARHGAP32 |
Rho GTPase activating protein 32 |
chr4_-_66536057 | 0.50 |
ENST00000273854.3 |
EPHA5 |
EPH receptor A5 |
chr19_+_15160130 | 0.50 |
ENST00000427043.3 |
CASP14 |
caspase 14, apoptosis-related cysteine peptidase |
chr4_+_106631966 | 0.49 |
ENST00000360505.5 ENST00000510865.1 ENST00000509336.1 |
GSTCD |
glutathione S-transferase, C-terminal domain containing |
chr6_-_26235206 | 0.49 |
ENST00000244534.5 |
HIST1H1D |
histone cluster 1, H1d |
chr2_-_220264703 | 0.49 |
ENST00000519905.1 ENST00000523282.1 ENST00000434339.1 ENST00000457935.1 |
DNPEP |
aspartyl aminopeptidase |
chr7_-_140482926 | 0.49 |
ENST00000496384.2 |
BRAF |
v-raf murine sarcoma viral oncogene homolog B |
chrX_-_138724994 | 0.49 |
ENST00000536274.1 |
MCF2 |
MCF.2 cell line derived transforming sequence |
chr4_-_186696425 | 0.49 |
ENST00000430503.1 ENST00000319454.6 ENST00000450341.1 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr20_-_33735070 | 0.47 |
ENST00000374491.3 ENST00000542871.1 ENST00000374492.3 |
EDEM2 |
ER degradation enhancer, mannosidase alpha-like 2 |
chr7_-_86849883 | 0.47 |
ENST00000433078.1 |
TMEM243 |
transmembrane protein 243, mitochondrial |
chrX_-_77225135 | 0.47 |
ENST00000458128.1 |
PGAM4 |
phosphoglycerate mutase family member 4 |
chr3_-_171528227 | 0.46 |
ENST00000356327.5 ENST00000342215.6 ENST00000340989.4 ENST00000351298.4 |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
chr1_-_151431647 | 0.45 |
ENST00000368863.2 ENST00000409503.1 ENST00000491586.1 ENST00000533351.1 ENST00000540984.1 |
POGZ |
pogo transposable element with ZNF domain |
chrX_-_33229636 | 0.45 |
ENST00000357033.4 |
DMD |
dystrophin |
chr8_+_77593448 | 0.45 |
ENST00000521891.2 |
ZFHX4 |
zinc finger homeobox 4 |
chr12_+_8276224 | 0.45 |
ENST00000229332.5 |
CLEC4A |
C-type lectin domain family 4, member A |
chr4_-_100356291 | 0.45 |
ENST00000476959.1 ENST00000482593.1 |
ADH7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr7_-_37026108 | 0.44 |
ENST00000396045.3 |
ELMO1 |
engulfment and cell motility 1 |
chr10_-_115904361 | 0.44 |
ENST00000428953.1 ENST00000543782.1 |
C10orf118 |
chromosome 10 open reading frame 118 |
chr16_+_30675654 | 0.44 |
ENST00000287468.5 ENST00000395073.2 |
FBRS |
fibrosin |
chr6_+_26402465 | 0.44 |
ENST00000476549.2 ENST00000289361.6 ENST00000450085.2 ENST00000425234.2 ENST00000427334.1 ENST00000506698.1 |
BTN3A1 |
butyrophilin, subfamily 3, member A1 |
chr4_-_46911248 | 0.44 |
ENST00000355591.3 ENST00000505102.1 |
COX7B2 |
cytochrome c oxidase subunit VIIb2 |
chr19_-_36304201 | 0.43 |
ENST00000301175.3 |
PRODH2 |
proline dehydrogenase (oxidase) 2 |
chr10_-_115614127 | 0.43 |
ENST00000369305.1 |
DCLRE1A |
DNA cross-link repair 1A |
chr19_+_56159509 | 0.43 |
ENST00000586790.1 ENST00000591578.1 ENST00000588740.1 |
CCDC106 |
coiled-coil domain containing 106 |
chr6_-_41701581 | 0.43 |
ENST00000394283.1 |
TFEB |
transcription factor EB |
chr6_+_96969672 | 0.42 |
ENST00000369278.4 |
UFL1 |
UFM1-specific ligase 1 |
chr8_-_90996837 | 0.42 |
ENST00000519426.1 ENST00000265433.3 |
NBN |
nibrin |
chr8_-_42623747 | 0.42 |
ENST00000534622.1 |
CHRNA6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
chr4_-_46911223 | 0.42 |
ENST00000396533.1 |
COX7B2 |
cytochrome c oxidase subunit VIIb2 |
chr6_+_26104104 | 0.42 |
ENST00000377803.2 |
HIST1H4C |
histone cluster 1, H4c |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 2.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 2.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 2.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 2.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 3.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 4.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 2.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 2.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 1.2 | GO:0036026 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.3 | 5.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 5.1 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 1.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.6 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.3 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.1 | 1.2 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.6 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 2.1 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0035061 | Smc5-Smc6 complex(GO:0030915) interchromatin granule(GO:0035061) |
0.1 | 0.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.8 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 4.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 2.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 2.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 0.9 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.2 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.0 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.9 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 5.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 1.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 1.1 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.0 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.0 | 0.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 2.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 1.9 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 1.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.6 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
1.1 | 3.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.8 | 2.5 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.6 | 1.9 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.6 | 1.8 | GO:2001248 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.6 | 1.7 | GO:1902948 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.5 | 2.2 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.5 | 1.5 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.5 | 1.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.4 | 2.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.5 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.4 | 1.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 1.7 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 1.6 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 8.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 1.0 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.3 | 0.9 | GO:0060369 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.3 | 0.8 | GO:0032641 | negative regulation of tolerance induction(GO:0002644) lymphotoxin A production(GO:0032641) interleukin-4 biosynthetic process(GO:0042097) lymphotoxin A biosynthetic process(GO:0042109) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 0.8 | GO:0048391 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.3 | 1.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 2.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 1.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 1.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) bone marrow development(GO:0048539) |
0.2 | 2.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 2.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.7 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.2 | 1.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.9 | GO:0006114 | glycerol biosynthetic process(GO:0006114) response to methionine(GO:1904640) |
0.2 | 0.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.2 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.6 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.2 | 1.0 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.2 | 0.5 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.7 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.2 | 0.5 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 0.6 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.2 | 0.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.8 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 0.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.7 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 2.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 1.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 5.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 3.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 1.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 5.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 1.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 1.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 1.1 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.4 | GO:1904798 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.3 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.3 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.1 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 1.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.2 | GO:0060920 | atrioventricular node development(GO:0003162) cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.3 | GO:0015692 | lead ion transport(GO:0015692) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.1 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.2 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.1 | 0.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 2.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 1.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 1.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.2 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.4 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 0.9 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 4.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.5 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.1 | 1.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:0048382 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) mesendoderm development(GO:0048382) |
0.0 | 0.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 1.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.6 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 1.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
0.0 | 1.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 1.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 5.1 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 2.6 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 1.1 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.1 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.0 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.3 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
0.0 | 0.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.0 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.2 | GO:0035546 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.0 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.2 | GO:1903557 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.0 | 0.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 | 0.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 1.5 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.0 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 1.0 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.7 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.2 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.3 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 2.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.5 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 1.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 1.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 1.0 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.4 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.4 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.0 | 0.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 1.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.2 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 1.0 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.2 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 1.8 | GO:0046777 | protein autophosphorylation(GO:0046777) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 3.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 3.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 2.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 1.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 5.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 2.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 1.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 1.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 7.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.7 | 2.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 1.8 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.6 | 2.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 2.0 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.4 | 1.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 2.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 0.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.3 | 2.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 1.0 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 0.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.7 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.2 | 0.8 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 0.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.2 | 5.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 2.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.9 | GO:0070404 | NADH binding(GO:0070404) |
0.2 | 3.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 1.7 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 1.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 2.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 3.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.4 | GO:0070260 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.1 | 0.5 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 6.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.4 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 2.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 4.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.4 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.3 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 0.2 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.1 | 0.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.0 | 0.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 2.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 6.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 3.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 1.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 1.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.5 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 1.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.4 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 1.2 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |